Options
A 48-Week, Multicenter, Open-Label, Observational Study Evaluating Oral Rivastigmine in Patients with Mild-to-Moderate Alzheimer’s Disease in Taiwan
Journal
Advances in Therapy
Journal Volume
36
Journal Issue
6
Start Page
1455-1464
ISSN
0741-238X
1865-8652
Date Issued
2019-04-05
Author(s)
Chiung-Chih Chang
Giia-Sheun Peng
Te-Jen Lai
Chien-Hsun Li
Ching-Kuan Liu
SDGs
Publisher
Springer Science and Business Media LLC
Type
journal-article